Figure 8c,d shows the distributions of EpCAM and GPC‐3 mRNA and protein levels, which were calibrated with the ASGPR protein, among early‐stage HCC patients, mid‐to‐late‐stage HCC patients, and healthy donors. This evidence concerns the gene GPC3 and hepatocellular carcinoma.